The growth in the heart closure devices market from 2024-2030 is mainly driven by several factors: the rising incidence of congenital heart defects, increased use of MRI procedures, greater awareness of cardiac irregularities in children, and ongoing innovations in product development. These elements collectively contribute to the heart closure devices market's expansion during the forecast period. LAS VEGAS , Aug.
27, 2024 /PRNewswire/ -- DelveInsight's Heart Closure Devices Market Insights report provides the current and forecast market analysis, individual leading heart closure devices companies' market shares, challenges, heart closure devices market drivers, barriers, trends, and key market heart closure devices companies in the market. Key Takeaways from the Heart Closure Devices Market Report As per DelveInsight estimates, North America is anticipated to dominate the global heart closure devices market during the forecast period. In the closure type segment of the heart closure devices market, the patent foramen ovale category (PFO closure) had a significant revenue share in the year 2023.
Notable heart closure devices companies such as Abbott, W. L. Gore & Associates, Inc.
, Boston Scientific Corporation, Occlutech, Heartstitch, SMT, Cardia, Inc., Lifetech Scientific, Lepu Medical Technology( Beijing )Co., Ltd.
, ATRICURE, INC., and several others, are currently operating in the heart closure devices market. In September 2022 , Abbott announced the European launch of it.